 The purpose of this study is to compare 12-month results of two single initial treatmentsphotodynamic therapy with verteporfin alone and this therapy combined with intravitreal bevacizumabfor neovascular age-related macular degeneration, not including patients with polypoidal choroidal vasculopathy who were presumed to have age-related macular degeneration. 